These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9482538)

  • 1. Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.
    Licinio J; Kling MA; Hauser P
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):30-8. PubMed ID: 9482538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood and cognitive side effects of interferon-alpha therapy.
    Valentine AD; Meyers CA; Kling MA; Richelson E; Hauser P
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):39-47. PubMed ID: 9482539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
    Amodio P; De Toni EN; Cavalletto L; Mapelli D; Bernardinello E; Del Piccolo F; Bergamelli C; Costanzo R; Bergamaschi F; Poma SZ; Chemello L; Gatta A; Perini G
    J Affect Disord; 2005 Jan; 84(1):93-8. PubMed ID: 15620390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].
    Capuron L; Dantzer R; Miller AH
    J Soc Biol; 2003; 197(2):151-6. PubMed ID: 12910630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a cytokine model of cognitive function.
    McAfoose J; Baune BT
    Neurosci Biobehav Rev; 2009 Mar; 33(3):355-66. PubMed ID: 18996146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and psychopathology: lessons from interferon-alpha.
    Capuron L; Miller AH
    Biol Psychiatry; 2004 Dec; 56(11):819-24. PubMed ID: 15576057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychiatric symptoms related to interferon alpha].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
    Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
    Capuron L; Ravaud A; Miller AH; Dantzer R
    Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive dysfunction in cancer patients.
    Meyers CA
    Oncology (Williston Park); 2000 Jan; 14(1):75-9; discussion 79, 81-2, 85. PubMed ID: 10680150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects.
    Orsal AS; Blois SM; Bermpohl D; Schaefer M; Coquery N
    Neuropsychobiology; 2008; 58(3-4):211-22. PubMed ID: 19212136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood and cognitive disorders in cancer patients receiving cytokine therapy.
    Meyers CA
    Adv Exp Med Biol; 1999; 461():75-81. PubMed ID: 10442168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
    Benedict RH; Carone DA; Bakshi R
    J Neuroimaging; 2004 Jul; 14(3 Suppl):36S-45S. PubMed ID: 15228758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.
    Birzniece V; Bäckström T; Johansson IM; Lindblad C; Lundgren P; Löfgren M; Olsson T; Ragagnin G; Taube M; Turkmen S; Wahlström G; Wang MD; Wihlbäck AC; Zhu D
    Brain Res Rev; 2006 Aug; 51(2):212-39. PubMed ID: 16368148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS.
    Arsenijevic D; Garcia I; Vesin C; Vesin D; Arsenijevic Y; Seydoux J; Girardier L; Ryffel B; Dulloo A; Richard D
    Eur Cytokine Netw; 2000 Dec; 11(4):662-8. PubMed ID: 11125311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Oxenkrug GF
    Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha.
    Jones TH; Wadler S; Hupart KH
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):54-63. PubMed ID: 9482541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome characterization of human NK-92 cells identifies novel IFN-alpha and IL-15 target genes.
    Rakkola R; Matikainen S; Nyman TA
    J Proteome Res; 2005; 4(1):75-82. PubMed ID: 15707360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.
    Stylianou E; Aukrust P; Müller F; Nordøy I; Frøland SS
    Cytokine; 2001 Apr; 14(1):56-62. PubMed ID: 11298493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C.
    Hilsabeck RC; Hassanein TI; Ziegler EA; Carlson MD; Perry W
    J Int Neuropsychol Soc; 2005 Jan; 11(1):16-22. PubMed ID: 15686604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reorganization of the human central nervous system.
    Schalow G; Zäch GA
    Gen Physiol Biophys; 2000 Oct; 19 Suppl 1():11-240. PubMed ID: 11252267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.